Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Profound Medical stock surges as Texas program expands access to TULSA prostate treatment under Medicare Profound Medical stock surged after Texas expanded access to its TULSA procedure under Medicare. Explore the financials, risks, and investor outlook. byPallavi MadhirajuSeptember 23, 2025